Cargando…

Treatment and Outcomes for Cutaneous Periauricular Basal Cell Carcinoma: A 16-Year Institutional Experience

OBJECTIVE: To report a single institutional experience with the surgical management of cutaneous periauricular basal cell carcinoma. STUDY DESIGN: Retrospective chart review. SETTING: Tertiary academic center. METHODS: Retrospective chart review of 71 patients diagnosed with periauricular basal cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, Mallory, Smith, Joshua D., Kovatch, Kevin J., McLean, Scott, Durham, Alison B., Basura, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580161/
https://www.ncbi.nlm.nih.gov/pubmed/33150296
http://dx.doi.org/10.1177/2473974X20964735
_version_ 1783598736090333184
author Peters, Mallory
Smith, Joshua D.
Kovatch, Kevin J.
McLean, Scott
Durham, Alison B.
Basura, Gregory
author_facet Peters, Mallory
Smith, Joshua D.
Kovatch, Kevin J.
McLean, Scott
Durham, Alison B.
Basura, Gregory
author_sort Peters, Mallory
collection PubMed
description OBJECTIVE: To report a single institutional experience with the surgical management of cutaneous periauricular basal cell carcinoma. STUDY DESIGN: Retrospective chart review. SETTING: Tertiary academic center. METHODS: Retrospective chart review of 71 patients diagnosed with periauricular basal cell carcinoma managed surgically from 2000 to 2016. Data were analyzed with descriptive statistics. RESULTS: The median age at diagnosis was 73.0 years (interquartile range, 13.0). Of all lesions, 2.8% (n = 2) were preauricular, 80.3% (n = 57) auricular, and 16.9% (n=12) postauricular. Auricular subsites included conchal bowl (36.6%, n = 26), helix (21.1%, n = 15), antihelix (1.4%, n = 1), peritragus (5.6%, n = 4), triangular fossa (1.4%, n = 1), external auditory canal (2.8%, n = 2), and lobule skin (1.4%, n = 1). Surgical approach included wide local excision (80.3%, n = 57), partial auriculectomy (8.5%, n = 6), and total auriculectomy or other combinations of surgical methods (11.3%, n = 8). Due to aggressive pathology, 3 cases required concurrent parotidectomy, neck dissection, ear canal sleeve resection, or mastoidectomy. In sum, 52.1% (n = 37) of cases had clear margins on first pass in the operating room; 25.4% (n = 18) required further resection; and 12.7% (n = 9) demonstrated final positive/overturned margins read as negative from the frozen sections. Reconstruction included full-thickness (25.4%, n = 18) or superficial-thickness (29.6%, n = 21) skin grafts and local flap reconstruction (25.4%, n = 18), while 5.6% (n = 4) required combinations of free flap and/or other reconstruction techniques; 14.1% (n = 10) did not undergo formal reconstruction. CONCLUSION: Periauricular basal cell carcinoma occurs in anatomically diverse locations in and around the ear, and multiple surgical methods are required for successful treatment.
format Online
Article
Text
id pubmed-7580161
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-75801612020-11-03 Treatment and Outcomes for Cutaneous Periauricular Basal Cell Carcinoma: A 16-Year Institutional Experience Peters, Mallory Smith, Joshua D. Kovatch, Kevin J. McLean, Scott Durham, Alison B. Basura, Gregory OTO Open Original Research OBJECTIVE: To report a single institutional experience with the surgical management of cutaneous periauricular basal cell carcinoma. STUDY DESIGN: Retrospective chart review. SETTING: Tertiary academic center. METHODS: Retrospective chart review of 71 patients diagnosed with periauricular basal cell carcinoma managed surgically from 2000 to 2016. Data were analyzed with descriptive statistics. RESULTS: The median age at diagnosis was 73.0 years (interquartile range, 13.0). Of all lesions, 2.8% (n = 2) were preauricular, 80.3% (n = 57) auricular, and 16.9% (n=12) postauricular. Auricular subsites included conchal bowl (36.6%, n = 26), helix (21.1%, n = 15), antihelix (1.4%, n = 1), peritragus (5.6%, n = 4), triangular fossa (1.4%, n = 1), external auditory canal (2.8%, n = 2), and lobule skin (1.4%, n = 1). Surgical approach included wide local excision (80.3%, n = 57), partial auriculectomy (8.5%, n = 6), and total auriculectomy or other combinations of surgical methods (11.3%, n = 8). Due to aggressive pathology, 3 cases required concurrent parotidectomy, neck dissection, ear canal sleeve resection, or mastoidectomy. In sum, 52.1% (n = 37) of cases had clear margins on first pass in the operating room; 25.4% (n = 18) required further resection; and 12.7% (n = 9) demonstrated final positive/overturned margins read as negative from the frozen sections. Reconstruction included full-thickness (25.4%, n = 18) or superficial-thickness (29.6%, n = 21) skin grafts and local flap reconstruction (25.4%, n = 18), while 5.6% (n = 4) required combinations of free flap and/or other reconstruction techniques; 14.1% (n = 10) did not undergo formal reconstruction. CONCLUSION: Periauricular basal cell carcinoma occurs in anatomically diverse locations in and around the ear, and multiple surgical methods are required for successful treatment. SAGE Publications 2020-10-19 /pmc/articles/PMC7580161/ /pubmed/33150296 http://dx.doi.org/10.1177/2473974X20964735 Text en © The Authors 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Peters, Mallory
Smith, Joshua D.
Kovatch, Kevin J.
McLean, Scott
Durham, Alison B.
Basura, Gregory
Treatment and Outcomes for Cutaneous Periauricular Basal Cell Carcinoma: A 16-Year Institutional Experience
title Treatment and Outcomes for Cutaneous Periauricular Basal Cell Carcinoma: A 16-Year Institutional Experience
title_full Treatment and Outcomes for Cutaneous Periauricular Basal Cell Carcinoma: A 16-Year Institutional Experience
title_fullStr Treatment and Outcomes for Cutaneous Periauricular Basal Cell Carcinoma: A 16-Year Institutional Experience
title_full_unstemmed Treatment and Outcomes for Cutaneous Periauricular Basal Cell Carcinoma: A 16-Year Institutional Experience
title_short Treatment and Outcomes for Cutaneous Periauricular Basal Cell Carcinoma: A 16-Year Institutional Experience
title_sort treatment and outcomes for cutaneous periauricular basal cell carcinoma: a 16-year institutional experience
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580161/
https://www.ncbi.nlm.nih.gov/pubmed/33150296
http://dx.doi.org/10.1177/2473974X20964735
work_keys_str_mv AT petersmallory treatmentandoutcomesforcutaneousperiauricularbasalcellcarcinomaa16yearinstitutionalexperience
AT smithjoshuad treatmentandoutcomesforcutaneousperiauricularbasalcellcarcinomaa16yearinstitutionalexperience
AT kovatchkevinj treatmentandoutcomesforcutaneousperiauricularbasalcellcarcinomaa16yearinstitutionalexperience
AT mcleanscott treatmentandoutcomesforcutaneousperiauricularbasalcellcarcinomaa16yearinstitutionalexperience
AT durhamalisonb treatmentandoutcomesforcutaneousperiauricularbasalcellcarcinomaa16yearinstitutionalexperience
AT basuragregory treatmentandoutcomesforcutaneousperiauricularbasalcellcarcinomaa16yearinstitutionalexperience